Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in alzheimer's disease
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2012
|
| In: |
Dementia and geriatric cognitive disorders
Year: 2012, Jahrgang: 33, Heft: 5, Pages: 341-353 |
| ISSN: | 1420-8008 |
| Online-Zugang: |
|
| Verfasserangaben: | Cummings, Jeffrey; Froelich, Lutz ... |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1630624675 | ||
| 003 | DE-627 | ||
| 005 | 20230427035600.0 | ||
| 007 | tu | ||
| 008 | 121203s2012 xx ||||| 00| ||eng c | ||
| 035 | |a (DE-627)1630624675 | ||
| 035 | |a (DE-576)375980504 | ||
| 035 | |a (DE-599)BSZ375980504 | ||
| 035 | |a (OCoLC)1341049153 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in alzheimer's disease |c Cummings, Jeffrey; Froelich, Lutz ... |
| 264 | 1 | |c 2012 | |
| 300 | |a 13 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Cummings, Jeffrey L. |d 1948- |0 (DE-588)132176289 |0 (DE-627)519021568 |0 (DE-576)166224294 |4 oth | |
| 700 | 1 | |a Frölich, Lutz |d 1956- |0 (DE-588)1028327099 |0 (DE-627)730567516 |0 (DE-576)375813160 |4 oth | |
| 773 | 0 | 8 | |i In |t Dementia and geriatric cognitive disorders |d Basel : Karger, 1997 |g 33(2012), 5, Seite 341-353 |w (DE-627)22484721X |w (DE-600)1360843-5 |w (DE-576)057735670 |x 1420-8008 |7 nnas |a Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in alzheimer's disease |
| 773 | 1 | 8 | |g volume:33 |g year:2012 |g number:5 |g pages:341-353 |g extent:13 |a Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in alzheimer's disease |
| 951 | |a AR | ||
| 992 | |a 20121203 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 1028327099 |a Frölich, Lutz |m 1028327099:Frölich, Lutz |d 60000 |e 60000PF1028327099 |k 0/60000/ |p 2 | ||
| 999 | |a KXP-PPN1630624675 |e 3280314593 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"family":"Cummings","display":"Cummings, Jeffrey L.","given":"Jeffrey L.","role":"oth"},{"family":"Frölich","display":"Frölich, Lutz","given":"Lutz","role":"oth"}],"title":[{"title":"Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in alzheimer's disease","title_sort":"Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in alzheimer's disease"}],"origin":[{"dateIssuedDisp":"2012","dateIssuedKey":"2012"}],"type":{"bibl":"article-journal"},"relHost":[{"type":{"bibl":"periodical"},"disp":"Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in alzheimer's diseaseDementia and geriatric cognitive disorders","pubHistory":["8.1997 -"],"origin":[{"publisherPlace":"Basel ; Freiburg [u.a.]","dateIssuedDisp":"1997-","publisher":"Karger","dateIssuedKey":"1997"}],"title":[{"title_sort":"Dementia and geriatric cognitive disorders","title":"Dementia and geriatric cognitive disorders"}],"part":{"volume":"33","extent":"13","year":"2012","pages":"341-353","issue":"5","text":"33(2012), 5, Seite 341-353"},"id":{"issn":["1420-8008"],"zdb":["1360843-5"],"eki":["22484721X"]},"recId":"22484721X","language":["eng"]}],"recId":"1630624675","physDesc":[{"extent":"13 S."}],"language":["eng"],"name":{"displayForm":["Cummings, Jeffrey; Froelich, Lutz ..."]},"id":{"eki":["1630624675"]}} | ||
| SRT | |a RANDOMIZED2012 | ||